Form 4 for KVYO Klaviyo, Inc.
Accepted 2025-02-19 00:00:00 ET · period of report 2025-02-15 · accession 0001835830-25-000018 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-02-19 | 2025-02-15 | KVYO | Edmond Landon | CLO | C - Cnv Deriv | — | +7,500 | 302.5K | +3% | — |
| D | 2025-02-19 | 2025-02-15 | KVYO | Edmond Landon | CLO | F - Tax | $47.00 | -13.1K | 289.5K | -4% | -$613.5K |
| DM | 2025-02-19 | 2025-02-15 | KVYO | Edmond Landon | CLO | C - Cnv Deriv | $0.00 | -7,500 | 90.0K | -8% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Series A Common Stock | 2025-02-15 | C | A | 3,586 | — | 293,053 | D | — | — | (F2) Each share of Series B Common Stock is convertible at any time at the option of the holder into one share of Series A Common Stock and will automatically convert into shares of Series A Common Stock upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. The Series B Common Stock has no expiration date. (F4) Consists of (i) 92,086 shares of Series A Common Stock and (ii) 200,967 unvested RSUs awarded under the Issuer's 2023 Stock Option and Incentive Plan, each representing the contingent right to receive one share of Series A Common Stock upon vesting and settlement. |
| 2 | Common | Series A Common Stock | 2025-02-15 | C | A | 3,914 | — | 302,521 | D | — | — | (F2) Each share of Series B Common Stock is convertible at any time at the option of the holder into one share of Series A Common Stock and will automatically convert into shares of Series A Common Stock upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. The Series B Common Stock has no expiration date. |
| 3 | Common | Series A Common Stock | 2025-02-15 | F | D | 13,054 | $47.00 | 289,467 | D | — | — | |
| 4 | Derivative | Series B Common Stock | 2025-02-15 | C | D | 3,914 | $0.00 | 93,586 | D | — · — to — | 3,914 Series A Common Stock | (F2) Each share of Series B Common Stock is convertible at any time at the option of the holder into one share of Series A Common Stock and will automatically convert into shares of Series A Common Stock upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. The Series B Common Stock has no expiration date. |
| 5 | Derivative | Series B Common Stock | 2025-02-15 | C | D | 3,586 | $0.00 | 90,000 | D | — · — to — | 3,586 Series A Common Stock | (F5) Consists of 90,000 unvested RSUs awarded under the Issuer's 2015 Stock Incentive Plan, each representing the contingent right to receive one share of Series B Common Stock upon vesting and settlement. (F2) Each share of Series B Common Stock is convertible at any time at the option of the holder into one share of Series A Common Stock and will automatically convert into shares of Series A Common Stock upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. The Series B Common Stock has no expiration date. |